Targeting NF-κB/COX-2 signaling by soyasaponin I alleviates diclofenac-induced gastric ulceration in male albino rats

Cell Biochem Funct. 2024 Jan;42(1):e3927. doi: 10.1002/cbf.3927.

Abstract

Gastric ulceration is a prevalent worldwide clinical presentation due to altered gastric defense mechanisms. Nonsteroidal anti-inflammatory drugs are one of the common causes of gastric ulcers mediated by the release of inflammatory mediators. The study aimed to investigate the potential protective effect of soyasaponin I (soya) against diclofenac (DIC)-induced gastric ulcer in rats and to highlight the underlying mechanisms. The experiment was conducted on 40 male Wistar albino rats, equally distributed into five groups: control, DIC-induced ulcer (9 mg/kg/d, orally, twice daily for 3 days), ulcer/soya-, ulcer/ranitidine-, and ulcer/soya/selective nuclear factor kappa B inhibitor (JSH-23)-treated groups. The doses of soya, ranitidine, and JSH were 20, 25, and 5 mg/kg/d, respectively, given orally. Gastric specimens were prepared for gene and histological study and for biochemical analysis of gastric prostaglandin E2 (PGE2), oxidative markers, and inflammatory cytokines. The gastric samples were formalin-fixed, paraffin-embedded, and subjected to hematoxylin and eosin (H&E), PAS staining, and immunohistochemical assay for identification of nuclear factor kappa B (NF-κB), cyclooxygenase-2 (COX-2), and proliferation marker (Ki67) expressions. The findings revealed decreased gastric PGE2 and altered inflammatory and oxidative markers in the ulcer model group. The H&E staining showed mucosal injury characterized by mucosal surface defects and inflammatory cell infiltrations. The polymerase chain reaction (PCR) and immunohistochemistry demonstrated an upregulation of NF-κB and COX-2 expression at gene/protein levels; meanwhile, Ki67 downregulation. The soya-treated group showed maintained biochemical, histological, and PCR findings comparable to the ranitidine-treated group. The JSH-23-treated group still showed partial gastric protection with biochemical and immunohistochemical changes. Soyasaponin I ameliorated DIC-induced gastric ulcers by targeting the COX-2 activity through modulation of NF-κB signaling.

Keywords: immunohistochemistry; inflammation; oxidative stress; phytochemicals; rat stomach.

MeSH terms

  • Animals
  • Cyclooxygenase 2
  • Diclofenac
  • Dinoprostone
  • Eosine Yellowish-(YS)
  • Ki-67 Antigen
  • Male
  • NF-kappa B*
  • Oleanolic Acid / analogs & derivatives*
  • Phenylenediamines*
  • Ranitidine
  • Rats
  • Rats, Wistar
  • Saponins*
  • Stomach Ulcer* / chemically induced
  • Stomach Ulcer* / drug therapy
  • Ulcer

Substances

  • NF-kappa B
  • 4-methyl-N1-(3-phenylpropyl)benzene-1,2-diamine
  • Cyclooxygenase 2
  • soyasaponin I
  • Diclofenac
  • Ranitidine
  • Dinoprostone
  • Ki-67 Antigen
  • Eosine Yellowish-(YS)
  • Oleanolic Acid
  • Phenylenediamines
  • Saponins